Publication:
Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients

Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

CIKRIKCIOGLU, M. A.

OZDEMIR, A. A.

SEKIN, Y.

YALCIN, BURAK


GUNDOGDU, A.

Erkal, S. N.

Kazancioglu, RÜMEYZA

Advisor

Date

2015-09-01

Language

Type

Article

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Aim. Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients.

Description

Source

Keywords

Keywords

Citation

CIKRIKCIOGLU M. A. , OZDEMIR A. A. , SEKIN Y., YALCIN B., ALTAY M., GUNDOGDU A., Erkal S. N. , Kazancioglu R., ERKOC R., -Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients-, MINERVA UROLOGICA E NEFROLOGICA, cilt.67, ss.187-196, 2015

URI

https://hdl.handle.net/20.500.12645/7942

Collections

Yayınlar - Eserler
Tıp Fakültesi

Endorsement

Review

Supplemented By

Referenced By

4

Views

0

Downloads


Sustainable Development Goals